Cingulate Inc share price logo

Cingulate Inc

NASDAQ: CING

$4.86

+0.11

(+2.32%)

Live

as on

Cingulate Inc Stock Performance

as on October 3, 2026 at 2:04 am IST

  • Day's Low

    Day's High

    $4.81
    $4.89
    downward going graph

    1.03%

    Downside

    0.62%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.16
    $11.89
    downward going graph

    34.98%

    Downside

    144.65%

    Upside

    downward going graph

Cingulate Inc share price movements today

Previous Close
$4.75
Open
$4.86
Volume
22.9K
Market Cap
$72.0M
Day's Low - High
$4.81 - $4.89
52 Week Low - High
$3.16 - $11.89

Cingulate Inc Historical Returns

1 Month Return
-7.77 %
3 Month Return
-11.71 %
1 Year Return
+ 17 %
3 Year Return
-97.14 %
5 Year Return
0 %

Cingulate Inc Stock Fundamentals & Key Indicators

Check Cingulate Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$72.0M

EPS (TTM)

-5.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.99

Industry PE ratio

-3.04

PEG Ratio

-0.12

EBITDA

194.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-238.41%

Cingulate Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cingulate Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$72.0MNA-0.990.00%0.00%
StrongBuy$44.0B607.04%-23.170.00%0.00%
Neutral$76.9B-44.61%-24.13-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$77.3B28.74%18.1184.86%0.49%

Stock Returns calculator for Cingulate Inc Stock including INR - Dollar returns

The Cingulate Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cingulate Inc investment value today

Current value as on today

₹1,29,932

Returns

₹29,932

(+29.93%)

Returns from Cingulate Inc Stock

₹19,704 (+19.7%)

Dollar Impact

₹10,227 (+10.23%)

Analyst Recommendation on Cingulate Inc Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Cingulate Inc. Average target price of $21.2

Cingulate Inc Share Price Target

Get share price movements and forecasts by analysts on Cingulate Inc.

What analysts predicted

77.08%UPSIDE

Target Price

$21.2

Current Price

$4.86

Analyzed by

10 Analysts

Target

$21.20

Cingulate Inc target price $21.2, a slight upside of 77.08% compared to current price of $4.86. According to 10 analysts rating.

Indian Investors' Interest in Cingulate Inc Stock

Search interest for Cingulate Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Cingulate Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-2
-3
-3
-6
-3
-4
-5
-5
-7
-5
EBITDA
-2
-3
-3
-6
-3
-4
-5
-5
-7
213
Interest Expense
-
0
-
-
-
-
-
-1
-
0
Depreciation
0
0
0
0
0
0
0
0
0
219
Income Before Tax
-2
-3
-4
-6
-3
-4
-7
-6
-9
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-3
-4
-6
-3
-4
-7
-6
-9
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cingulate Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
Operating Income
-11
-7
-20
-17
-22
-15
-19
EBITDA
-11
-6
-19
-17
-22
-14
-19
Interest Expense
-
0
0
0
-
-
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-11
-7
-20
-17
-23
-16
-22
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-11
-7
-20
-17
-23
-16
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cingulate Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-3
-3
-6
-3
-4
-7
-6
-9
-5
Operating Cash Flow
-8
-1
-3
-4
-4
-4
-4
-3
-6
-5
Investing Cash Flow
0
0
0
0
-
0
-
0
0
0
Financing Cash Flow
9
1
13
6
1
4
1
8
21
8
Change in Cash
1
0
9
2
-2
0
-2
4
14
2

Cingulate Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-11
-7
-20
-17
-23
-15
-22
Operating Cash Flow
-9
-6
-10
-15
-15
-18
-17
Investing Cash Flow
2
0
0
0
0
0
0
Financing Cash Flow
6
7
26
4
9
30
16
Change in Cash
0
0
15
-11
-5
12
-1

Global Institutional Holdings in Cingulate Inc

Check out the Institutions with significant holdings in Cingulate Inc.

Funds
Holdings
Vanguard
3.82%
VANGUARD INDEX FUNDS
2.09%
Fidelity Concord Street Trust
0.47%
iShares
0.20%
VANGUARD VALLEY FORGE FUNDS
0.04%

Insights on Cingulate Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.9% return, outperforming this stock by 180.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.0% return, outperforming this stock by 549.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, CING stock has moved down by -97.1%

About Cingulate Inc

Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its pipeline for ADHD are two drug candidates: CTx-1301 (dexmethylphenidate), which is currently progressing through Phase 3 clinical trials, and CTx-1302 (dextroamphetamine). The company is also engaged in the advancement of CTx-2103, a candidate intended for the management of anxiety disorders. Founded in 2012, Cingulate Inc. maintains its corporate headquarters in Kansas City, Kansas.
OrganisationCingulate Inc
Headquarters1901 West 47th Place, Kansas City, KS, 66205, US
IndustryBiotechnology
CEOShane J. Schaffer

Key Management of Cingulate Inc

Name

Title

Mr. Downey Bryan Wade

Executive VP & Chief Commercial Officer

Dr. Shane J. Schaffer Pharm.D.

Co-Founder, CEO & Chairman of the Board

Dr. Matthew N. Brams M.D.

Co-Founder, Executive VP & Chief Medical Officer

Ms. Jennifer L. Callahan CPA

Executive VP, CFO & Secretary

Dr. Raul R. Silva M.D.

Co-Founder, Executive VP & Chief Science Officer

Mr. Thomas Dalton

Vice President of Investor & Public Relations

FAQs

What is Cingulate Inc share price today?

Cingulate Inc share price today is $4.86 as on . Cingulate Inc share today touched a day high of $4.89 and a low of $4.81.

What is the 52 week high and 52 week low for Cingulate Inc share?

Cingulate Inc share touched a 52 week high of $11.89 on and a 52 week low of $3.16 on . Cingulate Inc stock price today i.e. is trending at $4.86,which is 59.13% down from its 52 week high and 53.80% up from its 52 week low.

What is Cingulate Inc's market capitalisation today?

Cingulate Inc market capitalisation is $0.00T as on .

How to invest in Cingulate Inc Stock (CING) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cingulate Inc on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cingulate Inc Stock (CING) from India?

Indian investors can start investing in Cingulate Inc (CING) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Cingulate Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cingulate Inc share’s latest price of $4.86 as on October 2, 2026 at 8:34 pm IST, you will get 2.0576 shares of Cingulate Inc. Learn more about fractional shares .